1. International Diabetes Federation Atlas. 6th ed. 2013. Available at: http://www.idf.org/diabetesatlas.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. doi:10.2337/diacare.27.5.1047. [PubMed] [CrossRef] [Google Scholar]
3. Coppell KJ, Mann JI, Williams SM, Jo E, Dury PL, Miller JC, Parnell WR. Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 Adult Nutrition Survey. NZMJ [serial on the Internet] 2013;126:1370. Available at: https://www.nzma.org.nz/journal. [PubMed]
4. Armstrong DG, Cohen K, Courric S, Bharara M, Marston W. Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not. J Diabetes Sci Technol. 2011;5(6):1591–5. doi:10.1177/193229681100500636. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Joshy G, Kamalinie C, Dunn P, Simmons D, Lawrenson R. Ethnic disparities in causes of death among diabetes patients in the Waikato region of New Zealand. NZMJ [serial on the Internet] 123:1310. Available at: https://www.nzma.org.nz/journal. [PubMed]
6. National Institute for Health and Care Excellence. Preventing type 2 diabetes: population and community-level interventions, NICE Guidelines [PH35], 2011. Available at: http://www.nice.org.uk/guidance/PH35.
7. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic Foot disorders a clinical practice guide. J Foot Ankle Surg. 2006;45(5):S1–66. doi:10.1016/S1067-2516(07)60001-5. [PubMed] [CrossRef] [Google Scholar]
8. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA, editors. The Diabetic Foot. St Louis: Mosby; 2001. pp. 13–32. [Google Scholar]
9. Boyko EJ, Ahroni JH, Stensel V, Frosberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot study. Diabetes Care. 1999;22:1036–42. doi:10.2337/diacare.22.7.1036. [PubMed] [CrossRef] [Google Scholar]
10. Diabetes UK. State of the nation 2012 England. Available at: http://www.diabetes.org.uk/documents/reports/state-of-the-nation-2012.pdf.
11. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13:513–21. doi:10.2337/diacare.13.5.513. [PubMed] [CrossRef] [Google Scholar]
12. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157–62. doi:10.2337/diacare.22.1.157. [PubMed] [CrossRef] [Google Scholar]
13. Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin N Am. 2013;97(5):775–90. doi:10.1016/j.mcna.2013.03.007. [PubMed] [CrossRef] [Google Scholar]
14. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. Diabetic foot ulcers: Part I: Pathophysiology and prevention. J Am Acad Dermatol. [On-line serial] 2014;70(1):1.e1-e18. Available at: http://www.eblue.org/ [PubMed]
15. Haris M, Rathur HM, Boulton AJM. The diabetic foot. Clin Dermatol. 2007;25:109–20. doi:10.1016/j.clindermatol.2006.09.015. [PubMed] [CrossRef] [Google Scholar]
16. Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, et al. Lower extremity amputations–a review of global variability in incidence. Diabet Med. 2011;28(10):1144–53. doi:10.1111/j.1464-5491.2011.03279.x. [PubMed] [CrossRef] [Google Scholar]
17. Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsem*nt by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679–85. doi:10.2337/dc08-9021. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
18. Diabetes UK. Putting Feet First. 2009. Available at https://www.diabetes.org.uk/Documents/campaigning/Putting-feet-first-campaign.0213.pdf.
19. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care. 2004;27:901–7. doi:10.2337/diacare.27.4.901. [PubMed] [CrossRef] [Google Scholar]
20. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(Suppl):17S–22. doi:10.1016/j.jvs.2010.06.003. [PubMed] [CrossRef] [Google Scholar]
21. Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England. Diabetic Med. (Advance online publication): 2014. Available at: doi:10.1111/dme.12545. [PubMed]
22. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in diabetes. Diabetes Care. 2004;27(Suppl 1):S63–4. [PubMed] [Google Scholar]
23. McInnes A, Jeffcoate W, Vileikyte L, Game F, Lucas K, Higson N, et al. Foot care education in patients with diabetes at low risk of complications: a consensus statement. Diabet Med. 2011;28(2):162–7. doi:10.1111/j.1464-5491.2010.03206.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
24. National Institute for Health and Clinical Excellence. Diabetic foot problems: Evidence Update March 2013: A summary of selected new evidence relevant to NICE clinical guideline 119 ‘Inpatient management of diabetic foot problems’. 2011. Available at: http://www.nice.org.uk/guidance/cg119.
25. Bus SA, Waaijman R, Arts M, de Haart M, Busch-Westbroek T, van Baal J, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care. 2013;36(12):4109–16. doi:10.2337/dc13-0996. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
26. Ulbrecht JS, Hurley T, Mauger DT, Cavanagh PR. Prevention of recurrent foot ulcers with plantar-pressure based in-shoe orthoses: The CareFUL prevention multicenter randomized controlled trial. Diabetes Care. 2014;37(7):1982–9. doi:10.2337/dc13-2956. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
27. Bus SA, Valk GD, van Deursen RW, Armstrong DG, Caravaggi C, Hlaváček P, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev. 2008;24:S162–80. doi:10.1002/dmrr.850. [PubMed] [CrossRef] [Google Scholar]
28. Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2013:CD002302. [PubMed]
29. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions v5.1.0. Available at: http://www.cochrane.org/handbook.
30. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(6):e1000097. doi:10.1371/journal.pmed.1000097. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
31. Howick J. Oxford Centre for Evidence-based Medicine – Levels of Evidence. 2009. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
32. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84. doi:10.1136/jech.52.6.377. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
33. National Collaborating Centre for Methods and Tools. Quality checklist for health care intervention studies. Hamilton, ON: McMaster University; 2010. Available from :http://www.nccmt.ca/registry/view/eng/9.html.
34. Blackwell B, Aldridge R, Jacob S. A comparison of plantar pressure in patients with diabetic foot ulcers using different hosiery. Int J Low Extrem Wounds. 2002;1:174–8. doi:10.1177/153473460200100305. [PubMed] [CrossRef] [Google Scholar]
35. Veves A, Masson E, Fernando D, Boulton A. Use of experimental padded hosiery to reduce abnormal foot pressures in diabetic neuropathy. Diabetes Care. 1989;12:653–5. doi:10.2337/diacare.12.9.653. [PubMed] [CrossRef] [Google Scholar]
36. Veves AME, Fernando DJ, Boulton AJ. Studies of experimental hosiery in diabetic neuropathic patients with high foot pressures. Diabet Med. 1990;7:324–6. doi:10.1111/j.1464-5491.1990.tb01398.x. [PubMed] [CrossRef] [Google Scholar]
37. Garrow A, van Schie CH, Boulton AE. Reducing in-shoe plantar foot pressure in high-risk patients with diabetes. Diabetes Care. 2005;28:2001–6. doi:10.2337/diacare.28.8.2001. [PubMed] [CrossRef] [Google Scholar]
38. Murray HJ, Veves A, Young MJ, Richie DH, Boulton AJ. Role of experimental socks in the care of high-risk diabetic foot. Diabetes Care. 1993;16:1190–3. doi:10.2337/diacare.16.8.1190. [PubMed] [CrossRef] [Google Scholar]
39. Banchellini E, Maccharini S, Valentia D, Loredana R, Tedeschi A, Alessia S, et al. Use of nanotechnology-designed foot sock in the management of pre-ulcerative conditions in the diabetic foot: results of a single blind randomized study. Int J Low Extrem Wounds. 2008;7(2):82–7. doi:10.1177/1534734608318138. [PubMed] [CrossRef] [Google Scholar]
40. Yick KL, Cheung NC, Leung KY, Ng SP, Yip J, Lo WT, et al. Effects of different types of socks on plantar pressures, in-shoe temperature and humidity in diabetic patients. J Donghua Univ. 2013;30(5):397–400. [Google Scholar]
41. Herring KM, Richie DH. Friction blisters and sock fiber composition: a double blind study. J Am Podiatr Med Assoc. 1990;80(2):63–7. doi:10.7547/87507315-80-2-63. [PubMed] [CrossRef] [Google Scholar]
42. Veves A, Hay EM, Boulton AJM. The use of specially padded hosiery in the painful rheumatoid foot. Foot (Edinb) 1992;1(4):175–7. doi:10.1016/0958-2592(92)90002-7. [CrossRef] [Google Scholar]
43. Herring KM, Richie DH. Comparison of cotton and acrylic socks using a generic cushion sole design for runners. J Am Podiatr Med Assoc. 1993;83(9):515–22. doi:10.7547/87507315-83-9-515. [PubMed] [CrossRef] [Google Scholar]
44. Flot S, Hill V, Yamada W, McPoil TG, Cornwall MW. The effect of padded hosiery in reducing forefoot plantar pressures. Low Extrem. 1995;2(3):201–5. [Google Scholar]
45. Blackmore T, Ball N, Scurr J. The effect of socks on vertical and anteroposterior ground reaction forces in walking and running. Foot (Edinb) 2011;21(1):1–5. doi:10.1016/j.foot.2010.10.002. [PubMed] [CrossRef] [Google Scholar]
46. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT Statement to Randomized Trials of Non-pharmacologic Treatment: Explanation and Elaboration. Ann Intern Med. 2008;148:295–309. doi:10.7326/0003-4819-148-4-200802190-00008. [PubMed] [CrossRef] [Google Scholar]
47. Cook A, Douet L, Boutron I. Descriptions of non-pharmacological interventions in clinical trials. Br Med J. 2013;347:f5212. doi:10.1136/bmj.f5212. [PubMed] [CrossRef] [Google Scholar]
48. Hro´bjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Rasmussen JV, Hilden J, et al. Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. Int J Epidemiol. 2014;43(3):937–48. doi:10.1093/ije/dyt270. [PubMed] [CrossRef] [Google Scholar]
49. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med. 1992;9(1):55–7. doi:10.1111/j.1464-5491.1992.tb01714.x. [PubMed] [CrossRef] [Google Scholar]
50. Cowley MS, Boyko EJ, Shofer JB, Ahroni JH, Ledoux WR. Foot ulcer risk and location in relation to prospective clinical assessment of foot shape and mobility among persons with diabetes. Diabetes Res Clin Pract. 2008;82:226–32. doi:10.1016/j.diabres.2008.07.025. [PubMed] [CrossRef] [Google Scholar]
51. Armstrong DG, Peters EJ, Athanasiou KA, Lavery LA. Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? J Foot Ankle Surg. 1998;37(4):303–7. doi:10.1016/S1067-2516(98)80066-5. [PubMed] [CrossRef] [Google Scholar]
52. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26(4):1069–73. doi:10.2337/diacare.26.4.1069. [PubMed] [CrossRef] [Google Scholar]
53. Barnett, SJ. International protocol guidelines for plantar pressure measurement. Diabetic Foot J. 1:137-140.
54. Donaghue VM, Sarnow MR, Giurini JM, Chrzan JS, Habershaw GM, Veves A. Longitudinal in-shoe foot pressure relief achieved by specially designed footwear in high risk diabetic patients. Diabetes Res Clin Pract. 1996;31:109–14. doi:10.1016/0168-8227(96)01211-9. [PubMed] [CrossRef] [Google Scholar]
55. Mueller MJ, Hastings M, Commean PK, Smith KE, Pilgram TK, Robertson D, et al. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36(7):1009–17. doi:10.1016/S0021-9290(03)00078-2. [PubMed] [CrossRef] [Google Scholar]
56. Klaesner JW, Hastings MK, Zou D, Lewis C, Mueller MJ. Plantar tissue stiffness in patients with diabetes mellitus and peripheral neuropathy. Arch Phys Med Rehab. 2002;83(12):1796–801. doi:10.1053/apmr.2002.35661. [PubMed] [CrossRef] [Google Scholar]
57. Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008;24(Suppl 1):S19–24. doi:10.1002/dmrr.861. [PubMed] [CrossRef] [Google Scholar]
58. Bertaux E, Derler S, Rossi RM, Zeng X, Koehl L, Ventenat V. Textile, Physiological, and Sensorial Parameters in Sock Comfort. Text Res J. 2010;80(17):1803–10. doi:10.1177/0040517510369409. [CrossRef] [Google Scholar]
59. Dai XQ, Li Y, Zhang M, Cheung JTM. Effect of sock on biomechanical responses of foot during walking. Clin Biomech (Bristol, Avon) 2006;21:314–21. doi:10.1016/j.clinbiomech.2005.10.002. [PubMed] [CrossRef] [Google Scholar]
60. Aluigi L. The Difoprev system in treatment of the skin of the elderly: preliminary data obtained in patients with dryness and hyperkeratosis. J Vasc Diag. 2014;2:15–21. doi:10.2147/JVD.S50320. [CrossRef] [Google Scholar]
